Capai PLC
CPAI · Main Market · Financial Services · mcap £1.7m · 0.4p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 25 Aug 26 | Holding | Holding(s) in Company | |
| 07 Aug 26 | Clarification Re: Admission of Ordinary Shares
Clarification that 5.3m warrant shares and 64.9m fundraise shares admitted to Main Market on 10 August 2026. |
+2.0% | |
| 05 Aug 26 | Holding | Holding(s) in Company | |
| 05 Aug 26 | Fundraise | Fundraise
Fundraise of £280,000 via placing and subscription, with warrants granted to shareholders. |
−13.3% |
| 23 Jul 26 | Licence and Option Agreement for Ageotype
capAI enters exclusive licence and option agreement with R42 for Ageotype longevity platform, capMedical's first offering. |
+35.1% | |
| 09 Jul 26 | Extension of Licence and Option Agreements
Extended licence and option agreements for Author42, Movie42 and Gamers42 platforms to 7 July 2027. |
−2.4% | |
| 30 Jun 26 | Results | Half-year Results
Interim loss of £967,906 as capAI transitions to execution with new divisions, US listing and strengthened board. |
+4.5% |
| 16 Jun 26 | Board change | CapAI Chairman Professor Ronjon Nag Awarded OBE
Executive Chairman Professor Ronjon Nag awarded OBE for services to entrepreneurship and AI. |
+5.6% |
| 09 Jun 26 | CapMedia Platform Portfolio Update and Webinar
(the "Company" and, together with its subsidiaries, the "Group" or "capAI") |
+11.5% | |
| 07 May 26 | Exercise of Warrants
capAI plc (LSE: CPAI, OTCQB: CPIQF) announces that it has received notice of exercise of warrants ("Warrants") to subscribe for a total of 5,290,000 new ordinary shares of nominal value £0.0001 each in the capital of the |
−14.6% | |
| 05 May 26 | Holding | Holding(s) in Company | |
| 28 Apr 26 | Holding | Holding(s) in Company | |
| 21 Apr 26 | Routine | Result of AGM | |
| 21 Apr 26 | AGM Trading & Strategic Update
Game42 and Movie42 launch this week; Author42 hard launch progressing; capMedical initiatives under evaluation. |
+57.5% | |
| 27 Mar 26 | Routine | Notice of AGM | |
| 27 Feb 26 | Routine | Total Voting Rights | |
| 10 Feb 26 | Fundraise | Commercial and Strategy Update, Fundraising
capAI announces £252,500 fundraise and strategy update on longevity, publishing and AI tools |
+7.3% |
| 30 Jan 26 | Results | Final Results
capAI reported FY25 loss of £790,529 and repositioned as AI-focused incubation platform with £275,000 fundraising. |
+8.6% |
| 17 Dec 25 | Board and Committee Changes
Jack Allardyce appointed as Executive Director; Richard Edwards steps down; Professor Ronjon Nag becomes Executive Chairman. |
−1.9% | |
| 15 Dec 25 | Holding | Holding(s) in Company | |
| 18 Nov 25 | Soft Launch of Author42
capAI soft launches Author42, an AI platform for non-fiction book creation following 12-week beta. |
−5.3% | |
| 17 Nov 25 | Holding | Holding(s) in Company | |
| 17 Nov 25 | Holding | Holding(s) in Company | |
| 13 Nov 25 | Holding | Holding(s) in Company | |
| 05 Nov 25 | Commencement of Trading on OTCQB Venture Market
capAI commenced trading on OTCQB Venture Market in the US under ticker CPIQF. |
+9.0% | |
| 04 Nov 25 | Exercise of Warrants, TVR and Other Updates
Exercise of Warrants, Total Voting Rights, Grant of Conditional Awards / Share Options and Appointment of Corporate Broker |
−8.3% | |
| 15 Oct 25 | Delivery of Completion Notice for Creator42
Creator42 reaches minimum viable product readiness; 12-month licence period now effective from 14 October 2025. |
+11.1% | |
| 14 Oct 25 | Move to SETS Trading Platform
capAI shares transition from SETSqx to SETS trading platform on LSE, effective today. |
−3.1% | |
| 08 Oct 25 | Director dealing | Director/PDMR and PCA Shareholdings
capAI (LSE: CPAI) announces that it was notified on 8 October 2025 of the following transactions: |
−3.0% |
| 07 Oct 25 | Incorporation of capMedical Inc and Other Updates
capAI incorporated US subsidiary capMedical Inc and renamed UK subsidiaries; submitted prospectus to FCA. |
+5.3% | |
| 06 Oct 25 | Results | Results of GM, Share Consolidation and TVR
Results of General Meeting, Share Consolidation and Total Voting Rights |
−0.6% |
Company filings. Not investment advice.